Close

Varian Medical Systems Receives 510(k) clearance for fast and accurate Acuros Radiotherapy Treatment

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Philips Powers Smart Healing Environment via Partnerships

Phillips went ahead and announced its collaborations with four...

FDA Publishes Updated AI-Enabled Medical Devices List

FDA Publishes Updated AI-Enabled Medical Devices List The U.S. Food...

InterSystems and MyCLNQ Health Partner to Advance Patient Engagement Across Asia

Partnership helps hospitals to extend reach beyond existing facilities...

Medical Supplierz Links Healthcare Buyers and Manufacturers

Medical Supplierz, which happens to be a digital B2B procurement platform,...

Varian Medical Systems announced that it has received FDA 510(k) clearance for the Acuros capability offered initially in its brachytherapy treatment planning system. The Acuros clearance was awarded as part of the market-leading Eclipsetreatment planning system.

BrachyVision Acuros, recently introduced at the American Brachytherapy Society meeting in Toronto, Canada, enables superior dose calculation at unmatched speed. The system enables clinicians to rapidly calculate patient dose with an extremely high level of accuracy*.

Hosea Mitchell, head of Varian's brachytherapy business unit says, BrachyVision Acuros calculation times tend to average between three and eight minutes depending on the applicator used. By comparison, the same calculations could take hours or days using the standard Monte Carlo method.

Mitchell adds, Securing 510(k) clearance is an important milestone in making this exciting new planning system available to brachytherapy practitioners. Acuros represents a major step forward in terms of accuracy with timeframes that were previously thought unimaginable. It will help clinicians make better decisions about dose to their patients and further their knowledge to make treatments more accurate.

Varian is working exclusively with Transpire Inc., developers of Acuros, to bring the benefits of this fast and precise calculation method to the radiation oncology field. In so doing, Varian becomes the only brachytherapy supplier with this capability in a commercially available product.

Latest stories

Related stories

Philips Powers Smart Healing Environment via Partnerships

Phillips went ahead and announced its collaborations with four...

FDA Publishes Updated AI-Enabled Medical Devices List

FDA Publishes Updated AI-Enabled Medical Devices List The U.S. Food...

InterSystems and MyCLNQ Health Partner to Advance Patient Engagement Across Asia

Partnership helps hospitals to extend reach beyond existing facilities...

Medical Supplierz Links Healthcare Buyers and Manufacturers

Medical Supplierz, which happens to be a digital B2B procurement platform,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back